Health Care Businesses

Lilly, Merck, Pfizer starting research center

February 23, 2010
Associated Press
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
More

WellPoint gets tax delay in Obama health plan

February 22, 2010
Bloomberg News
Insurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional funding for expanding Medicaid, under a White House proposal
More

Teva gets European OK to sell generic of Lilly's Evista

February 19, 2010
Bloomberg News
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
More

Pfizer's Viagra patent partially rejected in Lilly fight

February 16, 2010
Bloomberg News
The patent on impotence drug Viagra was partially rejected after the U.S. Patent and Trademark Office said it wasn't different enough from a Chinese herb known as Horny Goat Weed. The patent was key to an infringement suit Pfizer filed in 2002 against Eli Lilly and Co. over its rival Cialis drug.
More

Cardinal Health laying off 49 at local warehouse

February 8, 2010
 IBJ Staff
Cardinal Health notified the state on Feb. 3 that it laid off 37 workers at the end of January and plans to lay off 12 more effective April 3.
More

Health care venture capital swoons in Indy, holds steady statewide

February 6, 2010
 IBJ Staff
The uncertainty of health care reform and a bad economy curtailed venture capital flow in 2009.
More

Hill-Rom profit up 40 percent

February 4, 2010
J.K. Wall
Batesville maker of hospital equipment meets analysts' expectations, then raises full-year profit forecast.
More

Enzon Pharmaceuticals sells Indy drug plant; 100 local jobs safe

February 1, 2010
New Jersey-based Enzon Pharmaceuticals Inc. has sold its Indianapolis plant that manufactures specialty drugs in a deal that could top $300 million. The buyer says that the operations, which employ about 100, will remain in the city.
More

Health care reform will go on regardless of federal government

January 30, 2010
 IBJ Staff
Massachusetts’ election of a Republican senator has put health reform legislation on life support. But for the health care industry, reform is a reality that isn’t going to die.
More

Bioanalytical Systems' CEO announces retirement

January 28, 2010
Peter Schnitzler
Struggling West Lafayette life science contract research firm will search nationally for a new permanent leader.
More

Lilly shares trade down after fourth-quarter profits falls

January 28, 2010
J.K. Wall
Analysts worry about dive in already paltry sales of new blood thinner Effient
More

Accounting charge dents Zimmer's fourth-quarter profits

January 28, 2010
J.K. Wall
But excluding special charges, Warsaw-based orthopedic implant maker grows profits 5 percent, easily beating expectations of Wall Street.
More

Express Scripts to add 182 pharmacy jobs by 2012

January 27, 2010
 IBJ Staff
Drug distribution firm that acquired former WellPoint subsidiary plans to consolidate specialty pharmacy work at local airport facility.
More

Lilly shares get boost from OK of rival's drug

January 26, 2010
 IBJ Staff and Bloomberg News
Shares of Lilly and partner Amylin rose on hopes that their new version of Byetta will be approved following U.S. regulators' clearance of a similar drug.
More

Medical imaging supplier moves to Indianapolis

January 19, 2010
Scott Olson
Associated X-Ray Services relocates headquarters from South Bend to Indianapolis and also announces the company has changed its name to AXS Imaging.
More

Biotech firm plans $28M Greenwood plant

January 19, 2010
Greenwood pharmaceutical firm Elona Biotechnologies plans to build a $28 million production facility and create 70 jobs to help develop a cheaper form of insulin that could gain significant market share.
More

FDA letters scold Lilly, others over marketing materials

January 13, 2010
Associated Press
The letter to Indianapolis-based Lilly cites a print advertisement for the antidepressant Cymbalta that did not adequately display information about the drug's side effects.
More

Roche taps new local CEO

January 12, 2010
J.K. Wall
Roche Diagnostics named a new CEO for its North American operations Tuesday to replace Michael Tillmann, who resigned on Friday.
More

Tillmann out as Roche Diagnostics CEO

January 11, 2010
J.K. Wall
The management change comes as the Indianapolis company's diabetes market share has been sliding. Roche says successor will be named "shortly."
More

Hill-Rom hires new CEO

January 7, 2010
 IBJ Staff
John J. Greisch was most recently president of international operations at Baxter International Inc.
More

FDA cancels meeting to review Lilly's Cymbalta

January 5, 2010
Associated Press
The agency said the meeting was canceled "to allow time for the FDA to review new information" about a proposed new use for the drug.
More

Health care software firm RealMed regains momentum

January 2, 2010
Peter Schnitzler
RealMed enjoys a nearly 99-percent renewal rate among its current customers and attracted 4,000 new doctors in 2009. Employment at the company is rising after a steady decline.
More

Corporations bet on insiders to bend reform

December 30, 2009
J.K. Wall
Indianapolis health care heavyweights are among those spending $635 million, employing 166 former aides to key congressional leaders and committees in health reform process.
More

Health care industry braces for reform

December 26, 2009
J.K. Wall
Congress is on the cusp of transforming health insurance—if it can pass a health reform bill that was losing popularity late in the year.
More

To keep sales force busy, Lilly takes on new drug

December 24, 2009
J.K. Wall
Eli Lilly and Co. has bought the rights to co-market a new cholesterol-fighting drug in the U.S., giving it a third heart drug for sales personnel to push.
More
Page  << 11 12 13 14 15 16 17 18 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. RKW's comments read like a modern "Chicken Little". As a Raintree resident for many years, "Yes, I'm ready for this." Matter of fact, I welcome The Farm because it's a development that compliments our town, brings new and desirable shopping & dining closer (specialty grocer, upscale shops, micro brew pub, etc), offers upscale condos for empty nesters who want to stay in Zionsville, is being planned and constructed by local, well-reputed firms and, of course, provides desirable non property tax benefits. We all knew the Pittman's were going to develop their property sooner than later. That one of the Pittman's will continue to live on the property helps assure The Farm will be everything promised. This also sets a standard for other developers as to the quality of future developments - which should keep an ugly Walmart at bay for decades. As we've no meglomaniac mayor, I seriously doubt Zionsville would ever aspire to over-priced statues or subsidized retail rents. And we already have a very nice public theater, the Zionsville Performing Arts Center, that meets our cultural needs quite nicely.

  2. Do we add (or subtract) these from the bounty we recieve from RTWFL, Daylight Savings Time, corporate tax giveaways, and the crack job IEDC is doing?? Or is Mike going to blame these on Mitch?

  3. Who makes Tater Tots? They would be a good sponsor, because $3 Million for the alleged "Greatest Spectacle In Racing" is taters. Tiny, tiny taters. But at least they are making up something of the losses accumulated over the years in this dying sport. Buttock in seat is certainly not doing it, nor eyeball on TV, as evidenced by the lack of both.

  4. We loved lakehouse and think the Arbor Village would be a great location. It is less than 2 miles from over 1000 rooftops in the 225,000 to over 1 million range. Many people could use the great fishers trail system to bike or walk there. Just an idea Scotty -- but maybe something closer to 3 Wiseman would good. The only microbrew in area is Ram (boring)

  5. True, it's an ESPN production, but ESPN is just another name for ABC Sports, or what used to be ABC Sports since ABC Sports no longer exists as a name. ESPN=ABC Sports= ESPN. ESPN is, according to Forbes "the world's most valuable media property" worth $40 billion. Despite that, they fired 400 people this week.

ADVERTISEMENT